Sensei Biotherapeutics Inc (SNSE NASDAQ) stock market data APIs
$9.0886
-0.49(-5.4%)
as of September 17, 2025
Try our APIs with
free plan!
Sensei Biotherapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. It also offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. It has a collaboration with The University of Washington to conduct preclinical studies for its solnerstotug program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
Prev. Close
9.0886
Open
8.6019
High
9.2397
Low
8.6019
52 wk Range
5-17.4
Market Cap
11 225 K
Shares Outstanding
1 261 K
EPS
-3.91
Beta
0.272
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sensei Biotherapeutics Inc data using free add-ons & libraries
Get Sensei Biotherapeutics Inc Fundamental Data
Sensei Biotherapeutics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -26 192 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-31
- EPS/Forecast: -0.24
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sensei Biotherapeutics Inc News
New
Sensei (SNSE) Q2 Loss Narrows 31%
Key Points - Loss per share was $(3.91) in Q2 2025 was narrower than the $(5.60) analyst estimate. - Operating expenses decreased sharply compared to Q2 2024, supporting a cash runway into the second...
Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
- Full data for Phase 1/2 dose expansion cohort expected by year-end 2025 - - Cash runway into the second quarter of 2026 - BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (...
Sensei Biotherapeutics to present cancer therapy data at ESMO 2025
BOSTON - Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a micro-cap biotech company currently valued at $8.77 million and trading at $6.96, will present clinical data from its Phase 1/2 trial of solnerst...
Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025
Sensei Biotherapeutics BOSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
